A Novel Functional Assay of Protein C in Human Plasma and fts Comparison with Amidolytic and Anticoagulant Assays

Summary

A simple and fast method for the quantitative determination of protein C activity in plasma is here described. The first step consists in the conversion of protein C in the test sample into activated protein C by means of an activator isolated from Southern Copperhead venom. Subsequently, the degradation of factor Va, in presence of protein C-deficient plasma, is measured by the prolongation of the prothrombin time which is proportional to the amount of protein C in the sample. The dose-response curve showed a linear relationship from 6 to 150% protein C activity and the inter- and intra-assay reproducibility was 3.5% and 5.6% respectively. In normal subjects, a mean of protein C level of 98 ± 15% of normal pooled plasma was found. Comparison with the anticoagulant assay in samples of patients with oral anticoagulant, liver cirrhosis, disseminated intravascular coagulation and severe preeclampsia revealed an excellent correlation (r = 0.94, p <0.001). Also, a similar correlation (r = 0.93, p <0.001) existed between amidolytic assay and the method here proposed for all the samples studied without including the oral anticoagulant group. These results allowed us to infer that this method evaluates the ability of protein C to interact with protein S, phospholipids, calcium ions and factor Va.

• References

• 1 Stenflo J. A new vitamin-K-dependent protein: Purification from bovine plasma and preliminary characterization. J Biol Chem 1976; 251: 355-363
• 2 Clouse LH, Comp PC. The regulation of hemostasis: The protein C system. N Engl J Med 1986; 314: 1298-1304
• 3 Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA 1981; 78: 2249-2252
• 4 Marlar R, Kleiss A, Griffin J. Mechanism of action of human activated protein C, a thrombin dependent anticoagulant enzyme. Blood 1982; 59: 1067-1072
• 5 Walker FJ. Regulation of activated protein C by protein S, the role of phospholipids in factor Va inactivation. J Biol Chem 1981; 256: 1128-1131
• 6 van Hinsbergh VW, Bertina RM, van Wijngaarden A, van Tilburg JH, Emeis JJ, Haverkate F. Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium. Blood 1985; 65: 444-451
• 7 Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-1375
• 8 Bertina RM, Broekmans AW, van der Linden IK, Mertens K. Protein C deficiency in a Dutch family with thrombotic disease. Thromb Haemostas 1982; 48: 1-5
• 9 Mannucci PM, Vigano S. Déficiences of protein C, an inhibitor of blood coagulation. Lancet 1982; 2: 463-467
• 10 Griffin JH, Mosher DF, Zimmerman TS, Kleiss AJ. Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation. Blood 1982; 60: 261-264
• 11 Vigano-D’Angelo S, Comp PC, Esmon CT, D’Angelo A. Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected diseases states. J Clin Invest 1986; 77: 416-425
• 12 Boyer C, Rothschild C, Wolf M, Amiral J, Meyer D, Larrieu MJ. A new method for the estimation of protein C by ELISA. Thromb Res 1984; 36: 579-589
• 13 Ikeda K, Stenflo J. A radioimmunoassay for protein C. Thromb Res 1985; 39: 297-306
• 14 Francis RB, Patch MJ. A functional assay for protein C in human plasma. Thromb Res 1983; 32: 605-613
• 15 Bertina RM, Broekmans AW, Krommenhoek-van EsC, van Wijngaarden A. The use of a functional and immunologic assay for plasma protein C in the study of the heterogeneity of congenital protein C deficiency. Thromb Haemostas 1984; 51: 1-5
• 16 Sala N, Owen WG, Collen DA. A functional assay of protein C in human plasma. Blood 1984; 63: 671-675
• 17 Comp PC, Nixon RR, Esmon CT. Determination of functional levels of protein C, an antithrombotic protein using thrombin-thrombomodulin complex. Blood 1984; 63: 15-21
• 18 Martinoli JL, Stoker K. Fast functional protein C assay using protac, a novel protein C activator. Thromb Res 1986; 43: 253-264
• 19 Francis Jr RB, Seyfert U. Rapid amidolytic assay for protein C in whole plasma using an activator the venom of Agkistrodon contortrix contortrix . Am J Clin Pathol 1987; 87: 619-625
• 20 Bertina R. Specificity of protein C and protein S assays. Res Clin Lab 1990; XX: 127-138
• 21 de Moerloose P, Reber G, Bouvier C. Spuriously low levels of protein C with Protac activation clotting assay. Thromb Haemostas 1988; 59: 543
• 22 Vigano-D’Angelo S, Gilardoni F, D’Angelo A. Evaluation of coa-gulometric assays in the assessment of protein C anticoagulant activity; variable sensitivity of commercial APTT reagents to the cofactor effect of protein S. Thromb Haemostas 1989; 62: 861-867
• 23 Guglielmone HA, Vides MA. Prothrombin time in the monitoring of oral anticoagulant: A comparison of results using different thromboplastin. Ann Biol Clin 1990; 48: 547-550
• 24 Pritchard JA, McDonald PC. Hypertensive Disorders in Pregnancy. In: Williams/Obstetrics. Pritchard JA, McDonald PC. (eds). Appleton-Centry Crofts/Norwalk; Connecticut: 1980. pp 667-670
• 25 Pitlick FA, Nemerson Y. Purification and Characterization of Tissue Factor Apoprotein. In: Methods in Enzymologv. Vol.XLV Proteolytic Enzymes, part B. Leonard L. (ed). Academic Press; New York: 1976. p 37-48
• 26 Guglielmone HA, Vides MA. A simple two-step procedure for isolation of protein C activator from Southern Copperhead venom. Rev Iberoam Thromb Hemostas 1990; 3-4: 197-199
• 27 Priessner KT. Biological relevance of the protein C system and laboratory diagnosis of protein C and protein S deficiences. Clin Sci 1990; 78: 351-364
• 28 Franchi F, Tripodi A, Valsecchi C, Mannucci PM. Functional assays of protein C: Comparison of two snake-venom assays with two thrombin assays. Thromb Haemostas 1988; 60: 145-147
• 29 España F, Estelles A, Aznar J, Gilaberto J. Assay of protein C in human plasma: comparison of amidolytic, coagulation and immunochemical assays. Thromb Res 1986; 44: 771-782
• 30 Marlar RA, Adcock DM, Madden RM. Hereditary dysfunctional protein C molecules (Type II): Assay characterization and proposed classification. Thromb Haemostas 1990; 63: 375-379